“Cost‑effectiveness Analysis of Apixaban Versus Other NOACs for the Prevention of Stroke in Italian Atrial Fibrillation Patients”. Farmeconomia. Health Economics and Therapeutic Pathways 15, no. 4 (December 22, 2014): 101–112. Accessed December 28, 2025. https://journals.seedstm.com/index.php/FE/article/view/971.